Testosterone Recovery after Neoadjuvant Gonadotropin-Releasing Hormone Antagonist versus Agonist on Permanent Iodine-125 Seed Brachytherapy in Prostate Cancer Patients: A Propensity Score Analysis.

MLA

Iwata, Takehiro, et al. “Testosterone Recovery after Neoadjuvant Gonadotropin-Releasing Hormone Antagonist versus Agonist on Permanent Iodine-125 Seed Brachytherapy in Prostate Cancer Patients: A Propensity Score Analysis.” Acta Medica Okayama, vol. 75, no. 6, Dec. 2021, pp. 705–11. EBSCOhost, https://doi.org/10.18926/AMO/62810.

APA

Iwata, T., Maruyama, Y., Kawada, T., Sadahira, T., Katayama, S., Takamoto, A., Sako, T., Wada, K., Edamura, K., Kobayashi, Y., Araki, M., Watanabe, M., Watanabe, T., & Nasu, Y. (2021). Testosterone Recovery after Neoadjuvant Gonadotropin-Releasing Hormone Antagonist versus Agonist on Permanent Iodine-125 Seed Brachytherapy in Prostate Cancer Patients: A Propensity Score Analysis. Acta Medica Okayama, 75(6), 705–711. https://doi.org/10.18926/AMO/62810

Chicago

Iwata, Takehiro, Yuki Maruyama, Tatsushi Kawada, Takuya Sadahira, Satoshi Katayama, Atsushi Takamoto, Tomoko Sako, et al. 2021. “Testosterone Recovery after Neoadjuvant Gonadotropin-Releasing Hormone Antagonist versus Agonist on Permanent Iodine-125 Seed Brachytherapy in Prostate Cancer Patients: A Propensity Score Analysis.” Acta Medica Okayama 75 (6): 705–11. doi:10.18926/AMO/62810.